Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
about
Common genetic variation and the control of HIV-1 in humansFive-transmembrane domains appear sufficient for a G protein-coupled receptor: functional five-transmembrane domain chemokine receptorsTrafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalizationEvaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance alleleThe coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIVHIV-1 induced bystander apoptosisThe spread, treatment, and prevention of HIV-1: evolution of a global pandemicA new classification for HIV-1In vitro correlates of HIV-2-mediated HIV-1 protectionAlteration of estrogen-regulated gene expression in human cells induced by the agricultural and horticultural herbicide glyphosateCyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cellsDifferential contribution of Puma and Noxa in dual regulation of p53-mediated apoptotic pathwaysGenomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strainsChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strainsSTRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 diseaseAkt phosphorylates acinus and inhibits its proteolytic cleavage, preventing chromatin condensationTAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humansDating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionSpirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitroStem-cell-based gene therapy for HIV infectionRole for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cellsNewer gene editing technologies toward HIV gene therapyCCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cellsTwo orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infectionInherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified riskTargeted genome editing in human cells with zinc finger nucleases constructed via modular assemblyBinding modes of CCR5-targetting HIV entry inhibitors: partial and full antagonistsSpontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free statusHIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulationCCR5 deficiency increases risk of symptomatic West Nile virus infectionHIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptorsAggressive HIV-1?Association studies for asthma and atopic diseases: a comprehensive review of the literatureLimited durability of viral control following treated acute HIV infectionGenetic epidemiology. Giant cell arteritis and polymyalgia rheumaticaHIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vectorLentiviral transduction of Tar Decoy and CCR5 ribozyme into CD34+ progenitor cells and derivation of HIV-1 resistant T cells and macrophages
P2860
Q21092450-A017B9E7-7D81-4420-8AA8-7F7B01139D16Q22010218-2B4EB534-8DC8-49D2-8844-23BA11657DDDQ22010658-AC347F97-CA8C-46AF-9414-BE398B3FB4FAQ22066229-0AF9DD16-A990-45A4-BDD6-2AD1D0B75B90Q22066237-C238C690-9FDC-4567-A769-0820854FBB8FQ22241221-B4AF517D-0972-4D3A-A478-39B0809E7C49Q22241890-0FD59BB9-2099-46A8-8778-682DE768159AQ22251292-18C9BA33-77FA-4954-B156-974CB08969B3Q22254217-B226E580-C3C7-44A3-A3C9-26347FD4EDD5Q23919770-681487B6-B8E9-4992-9272-CA8F1C944753Q24290922-68C69F72-2A9D-40B4-9759-EC75041E1424Q24306130-36E51E23-C9C5-44F4-BC71-C5A3381B79D7Q24310870-5740E14C-844F-449E-AAAB-A44DCA8DDC1AQ24316964-1DC3F670-2B8D-4EB8-9D23-2C940DAFAC37Q24319950-F8DBAD1C-9D3A-4A86-BE74-9040EDD51942Q24324020-51945CC1-35A5-49D6-B989-D5B24DEE8107Q24524292-CA7D1647-9A99-4982-8755-8687421AF6ECQ24537007-91236106-2210-46DC-AAA4-6C0B5BDEFBD3Q24537285-8C435809-5342-4317-A058-0A4885F7F914Q24538942-3FA7D994-2E3B-4A6E-B6EC-B3E1E178DCB3Q24550678-20C89FE3-AA11-4BD7-874B-94ED7C34676BQ24563937-3E961A26-1375-41D1-A5B4-B4A2C11D7EF3Q24607667-31FE8ECB-7516-472C-9E09-7301B39D8CCEQ24608200-2628BEF5-5C58-43F4-8F00-A437EE8267CEQ24631042-D632AE5F-C764-498A-801A-0F5DEC0662BEQ24652932-E2DB1B2D-F35A-4E51-A7D9-7F704DA3DC60Q24652969-B39CCC37-29B3-46CD-81F2-BAEDDB2076BCQ24654734-58B41CD5-D32C-49AD-BA8D-16DB78FE48C6Q24655166-73B1AB58-6764-480F-8637-228FE91467AFQ24658283-E83605FE-78AF-48A4-80E2-12A55FA13CE0Q24672737-E6C1EAA0-36E9-407C-8944-41495E074964Q24676438-6816A894-0082-457E-AAA9-029902837D3EQ24677652-464950B2-6CB2-4F96-8C05-23AE56AF89DCQ24682714-0FBCD4FF-B320-4639-B5E7-D0911A274C54Q24801219-FA4F885E-3C0C-4B98-A0EE-E58E22AF94C6Q24802474-C8185027-DA6F-407E-9ED4-A15F3815D598Q24804986-7FFE49F6-BB5F-43EC-B825-9ADFEAECC5D0Q24805430-AC68E64E-4D60-434A-8183-38CAE9F43463Q24806310-A37A7845-288D-4CA9-813C-3F577998BD21Q24806329-592808DD-F2B1-4757-BDF3-0F7428919962
P2860
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Homozygous defect in HIV-1 cor ...... individuals to HIV-1 infection
@ast
Homozygous defect in HIV-1 cor ...... individuals to HIV-1 infection
@en
type
label
Homozygous defect in HIV-1 cor ...... individuals to HIV-1 infection
@ast
Homozygous defect in HIV-1 cor ...... individuals to HIV-1 infection
@en
prefLabel
Homozygous defect in HIV-1 cor ...... individuals to HIV-1 infection
@ast
Homozygous defect in HIV-1 cor ...... individuals to HIV-1 infection
@en
P2093
P3181
P1433
P1476
Homozygous defect in HIV-1 cor ...... individuals to HIV-1 infection
@en
P2093
D Ceradini
M E MacDonald
N R Landau
S R Martin
W A Paxton
P304
P3181
P356
10.1016/S0092-8674(00)80110-5
P407
P577
1996-08-01T00:00:00Z